Phase 2 Connective Tissue Diseases Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
Pulmonary Arterial HypertensionConnective Tissue DiseasesIdiopathic Pulmonary Arterial Hypertension+1 more
Bastiaan Driehuys20 enrolled1 locationNCT06104228
Recruiting
Phase 2
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
ThrombocytopeniaConnective Tissue Diseases
Beijing Hospital296 enrolled23 locationsNCT05998759
Recruiting
Phase 2
Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
Connective Tissue DiseasesImmune ThrombocytopeniaEvan Syndrome+1 more
Institute of Hematology & Blood Diseases Hospital, China52 enrolled1 locationNCT04993885
Recruiting
Phase 1Phase 2
ADSCs Therapy in Patients With CTD-ILD
Interstitial Lung DiseaseConnective Tissue Diseases
China Medical University Hospital16 enrolled1 locationNCT06574581